1. Home
  2. KRO vs ARQT Comparison

KRO vs ARQT Comparison

Compare KRO & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRO
  • ARQT
  • Stock Information
  • Founded
  • KRO 1916
  • ARQT 2016
  • Country
  • KRO United States
  • ARQT United States
  • Employees
  • KRO N/A
  • ARQT N/A
  • Industry
  • KRO Major Chemicals
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRO Industrials
  • ARQT Health Care
  • Exchange
  • KRO Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • KRO 598.2M
  • ARQT 2.1B
  • IPO Year
  • KRO N/A
  • ARQT 2020
  • Fundamental
  • Price
  • KRO $6.23
  • ARQT $16.83
  • Analyst Decision
  • KRO Strong Sell
  • ARQT Strong Buy
  • Analyst Count
  • KRO 2
  • ARQT 7
  • Target Price
  • KRO $7.75
  • ARQT $19.00
  • AVG Volume (30 Days)
  • KRO 350.9K
  • ARQT 1.5M
  • Earning Date
  • KRO 11-05-2025
  • ARQT 11-05-2025
  • Dividend Yield
  • KRO 3.32%
  • ARQT N/A
  • EPS Growth
  • KRO 3452.79
  • ARQT N/A
  • EPS
  • KRO 0.59
  • ARQT N/A
  • Revenue
  • KRO $1,892,000,000.00
  • ARQT $263,464,999.00
  • Revenue This Year
  • KRO $5.77
  • ARQT $72.46
  • Revenue Next Year
  • KRO $11.07
  • ARQT $32.00
  • P/E Ratio
  • KRO $10.27
  • ARQT N/A
  • Revenue Growth
  • KRO 6.51
  • ARQT 99.50
  • 52 Week Low
  • KRO $4.70
  • ARQT $8.03
  • 52 Week High
  • KRO $12.98
  • ARQT $18.15
  • Technical
  • Relative Strength Index (RSI)
  • KRO 52.46
  • ARQT 52.40
  • Support Level
  • KRO $6.07
  • ARQT N/A
  • Resistance Level
  • KRO $6.39
  • ARQT $18.15
  • Average True Range (ATR)
  • KRO 0.24
  • ARQT 0.63
  • MACD
  • KRO -0.01
  • ARQT -0.59
  • Stochastic Oscillator
  • KRO 54.39
  • ARQT 92.73

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: